Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia
Clinical trial NCT05574608 · UNKNOWN
Trial details
- NCT number
- NCT05574608
- Sponsor
- Affiliated Hospital to Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-10-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.